+1 to InsuranceTom. Especially the point about "Re: GIP receptor pharmacology — the eff..." — I have seen the same in my own experience with GIP receptor pharmacology.
Want to share my personal experience related to GIP receptor pharmacology since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 255 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 12 months later: I am down 70 lbs, my labs have normalized, and I am off 2 of my 3 medications. The GIP receptor aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
hans_munich — that is really helpful context on GIP receptor pharmacology. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemTo answer TinaHashiRN's question specifically:
From a clinical standpoint, GIP receptor pharmacology is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
Saving this for reference. Quality thread.